Prognostic Impact of C-reactive Protein-Albumin-Lymphocyte Index in Patients Who Underwent Splenectomy and Devascularization for Gastric Varices Caused by Portal Hypertension

C反应蛋白-白蛋白-淋巴细胞指数对接受脾切除和血管离断术治疗门静脉高压所致胃静脉曲张患者的预后影响

阅读:1

Abstract

PURPOSE: The C-reactive protein-albumin-lymphocyte (CALLY) index is a novel nutritional and inflammation-based index. This study aimed to evaluate the prognostic value of the preoperative CALLY index in patients who underwent splenectomy and devascularization (Sp + Dev) for gastric varices caused by portal hypertension. METHODS: This study included 64 patients who underwent Sp + Dev for gastric varices between January 2009 and March 2022. The CALLY index was calculated as (albumin × lymphocyte)/(C-reactive protein × 10(4)), and the patients were divided into high and low CALLY groups. Log-rank tests were performed to compare the overall survival (OS). Independent risk factors for OS were identified by multivariate analysis. Propensity score-matching was performed for survival analysis to balance the selection bias for stratification of the CALLY index. RESULTS:  The cut-off value of the CALLY index was set at 4.35 using receiver-operating characteristic curve analysis, and 39 patients were classified into the low CALLY group. The low CALLY group had significantly worse OS (p = 0.013) than the high CALLY group. Multivariate analysis identified a low CALLY index (hazard ratio (HR) = 3.787; 95% confidence interval (CI) = 1.174-12.218; p = 0.026) and concurrent hepatocellular carcinoma (HR = 2.914; 95% CI = 1.018-8.342; p = 0.046) as independent risk factors for poor OS. After propensity score-matching to balance the selection bias, a low CALLY index significantly correlated with worse OS (p = 0.026). The low CALLY group had significantly worse portal vein pressure after splenectomy than the high CALLY group (p = 0.031). CONCLUSIONS: Preoperative CALLY index is a significant prognostic indicator for gastric varices after Sp + Dev. The CALLY index may be useful in determining the suitability of surgical treatment and perioperative management.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。